[Avant Droite] Jambe de suspension pour 2007-2010 Ford Edge Lincoln MKX KSH-100364 2020-audi-sq7 Numéro de pièce: KDA-100783 KDA-100498

Name: [Avant Droite] Jambe de suspension pour 2007-2010 Ford Edge Lincoln MKX KSH-100364 2020-audi-sq7 Numéro de pièce: KDA-100783 KDA-100498
Brand: ivancuevas.com
SKU: 20127817547
Price: 162.29 USD
Availability: InStock
Rating: 4.2916 (7 reviews)

SKU 20127817547 · ★ 4.3

EUR162.29EUR197.29

Pay in 4 interest-free payments of $40.57 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 13 - Nov 18

Harbor notes

Description

[Avant Droite] Jambe de suspension pour 2007 2010 Ford Edge Lincoln MKX KSH 100364 2020 audi sq7 Numéro de pièce: KDA 100783 KDA 100498 Numéro de pièce: KDA 100783 40094 BR901618 HO 5031 2941215 2488821903 3488821903 7488821903 901618 941215 610074 982055FZN 982055R 982055 AHO1025 BHO1025 PRC1832A 8840 AD8840 PF8840X QE8840X SG8840X SS8840X D1832A 1832A Produit: Jambe de suspension Pièces interchangeables OEM: 331688R G56841 334692 802888 72888 143415 SM5755 SM5756 902130 906962 K160206 K160369

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Frequently Asked Questions for [Avant Droite] Jambe de suspension pour 2007-2010 Ford Edge Lincoln MKX KSH-100364 2020-audi-sq7 Numéro de pièce: KDA-100783 KDA-100498

What should I check when reading a translated product listing?

Look for consistency between the final selection and the description you reviewed. Make the decision from verified meaning rather than the most favorable interpretation of translated wording.

How can I make a useful comparison table for several products?

Add relevant limitations alongside the positive features. Save the final comparison with the relevant purchase notes.

How can I check whether a purchase involves ongoing commitments?

Do not infer indefinite access or support from an unspecified term. Do not treat a trial label as a complete explanation of what follows it.